Academic literature on the topic 'Bifidobacterium lactis'

ABSTRACT Although the health-promoting roles of bifidobacteria are widely accepted, the diversity of bifidobacteria among the human intestinal microbiota is still poorly understood. We performed a census of bifidobacterial populations from human intestinal mucosal and fecal samples by plating them on selective medium, coupled with molecular analysis of selected rRNA gene sequences (16S rRNA gene and internally transcribed spacer [ITS] 16S-23S spacer sequences) of isolated colonies. A total of 900 isolates were collected, of which 704 were shown to belong to bifidobacteria. Analyses showed that the culturable bifidobacterial population from intestinal and fecal samples include six main phylogenetic taxa, i.e., Bifidobacterium longum, Bifidobacterium pseudocatenulatum, Bifidobacterium adolescentis, Bifidobacterium pseudolongum, Bifidobacterium breve, and Bifidobacterium bifidum, and two species mostly detected in fecal samples, i.e., Bifidobacterium dentium and Bifidobacterium animalis subp. lactis. Analysis of bifidobacterial distribution based on age of the subject revealed that certain identified bifidobacterial species were exclusively present in the adult human gut microbiota whereas others were found to be widely distributed. We encountered significant intersubject variability and composition differences between fecal and mucosa-adherent bifidobacterial communities. In contrast, a modest diversification of bifidobacterial populations was noticed between different intestinal regions within the same individual (intrasubject variability). Notably, a small number of bifidobacterial isolates were shown to display a wide ecological distribution, thus suggesting that they possess a broad colonization capacity.

ABSTRACT The relationship between Bifidobacterium lactis and Bifidobacterium animalis was examined by comparative analysis of tuf and recA gene sequences and by restriction fragment length polymorphism analysis of their internal 16S-23S transcribed spacer region sequences. The bifidobacterial strains investigated could be divided into two distinct groups within a single species based on the tuf, recA, and 16S-23S spacer region sequence analysis. Therefore, all strains of B. lactis and B. animalis could be unified as the species B. animalis and divided into two subspecies, Bifidobacterium animalis subsp. lactis and Bifidobacterium animalis subsp. animalis.

ABSTRACT Bifidobacteria constitute up to 3% of the total microbiota and represent one of the most important health-promoting bacterial groups of the human intestinal microflora. The presence of Bifidobacterium in the human gastrointestinal tract has been directly related to several health-promoting activities; however, to date, no information about the specific mechanisms of interaction with the host is available. In order to provide some insight into the molecular mechanisms involved in the interaction with the host, we investigated whether Bifidobacterium was able to capture human plasminogen on the cell surface. By using flow cytometry, we demonstrated a dose-dependent human plasminogen-binding activity for four strains belonging to three bifidobacterial species: Bifidobacterium lactis, B. bifidum, and B. longum. The binding of human plasminogen to Bifidobacterium was dependent on lysine residues of surface protein receptors. By using a proteomic approach, we identified five putative plasminogen-binding proteins in the cell wall fraction of the model strain B. lactis BI07. The data suggest that plasminogen binding to B. lactis is due to the concerted action of a number of proteins located on the bacterial cell surface, some of which are highly conserved cytoplasmic proteins which have other essential cellular functions. Our findings represent a step forward in understanding the mechanisms involved in the Bifidobacterium-host interaction.

Microbial colonization of the mammalian intestine begins at birth, when from a sterile state a newborn infant is exposed to an external environment rich in various bacterial species. An important group of intestinal bacteria comprises bifidobacteria. Bifidobacteria represent major intestinal microbiota during the breast-feeding period. Animal milk contains all crucial nutrients for babies’ intestinal microflora. The aim of our work was to test the influence of different mammalian milk on the growth of bifidobacteria. The growth of seven strains of bifidobacteria in human milk, the colostrum of swine, cow’s milk, sheep’s milk, and rabbit’s milk was tested. Good growth accompanied by the production of lactic acid was observed not only in human milk, but also in the other kinds of milk in all three strains of Bifidobacterium bifidum of different origin. Human milk selectively supported the production of lactic acid of human bifidobacterial isolates, especially the Bifidobacterium bifidum species. The promotion of bifidobacteria by milk is species-specific. Human milk contains a key factor for the growth of specific species or strains of human-origin bifidobacteria compared to other kinds of milk. In contrast, some components (maybe lysozyme) of human milk inhibited the growth of Bifidobacterium animalis. Animal-origin strains of bifidobacteria were not able to significantly grow even in milk of animal origin, with the exception of B. animalis subsp. lactis 1,2, which slightly grew in sheep’s milk.

Great interest in functional products containing bacterial strains displaying health-promoting properties is expressed worldwide and is as a result connected with a demand for developing new probiotic-based products, especially those containing bifidobacteria. The Bifidobacterium strains play a key role in gastrointestinal homeostasis, providing many health-related attributes, but as fastidious microorganisms require specific conditions (e.g. anaerobic environment, neutral pH) to survive in the long-term at the needed level above 10⁶ cfu/g. In consequence, not every food product guarantees optimal maintenance of Bifidobacterium viability. From this point of view, the objective of the study was to examine the survival of Bifidobacterium lactis strain in butter during long-term refrigerated storage. Two enumeration techniques: microscopic LIVE/DEAD^® and plating were compared by monitoring bifidobacterial counts for 4 weeks. The plate method was characterised by underestimation of the cell counts in relation to the results evaluated microscopically. However, the good survival exhibited by B. lactis was found with both techniques. Moreover, the microscopic LIVE/DEAD^® method permitted to trace delicate changes in the viable/non-viable bifidobacterial population at the single-cell level.  

Background: This study evaluated the impact of Bifidobacterium animalis ssp. lactis CNCM I-3446, Bovine Milk-derived OligoSaccharides (BMOS) and their combination on infant gut microbiota in vitro. In addition, a novel strategy consisting of preculturing B. lactis with BMOS to further enhance their potential synbiotic effects was assessed. Method: Short-term fecal batch fermentations (48 h) were used to assess the microbial composition and activity modulated by BMOS alone, B. lactis grown on BMOS or dextrose alone, or their combinations on different three-month-old infant microbiota. Results: BMOS alone significantly induced acetate and lactate production (leading to pH decrease) and stimulated bifidobacterial growth in 10 donors. A further in-depth study on two different donors proved B. lactis ability to colonize the infant microbiota, regardless of the competitiveness of the environment. BMOS further enhanced this engraftment, suggesting a strong synbiotic effect. This was also observed at the microbiota activity level, especially in a donor containing low initial levels of bifidobacteria. In this donor, preculturing B. lactis with BMOS strengthened further the early modulation of microbiota activity observed after 6 h. Conclusion: This study demonstrated the strong synbiotic effect of BMOS and B. lactis on the infant gut microbiota, and suggests a strategy to improve its effectiveness in an otherwise low-Bifidobacterium microbiota.

ABSTRACT Several strains belonging to the genus Bifidobacterium were tested to determine their abilities to produce succinic acid. Bifidobacterium longum strain BB536 and Bifidobacterium animalis subsp. lactis strain Bb 12 were kinetically analyzed in detail using in vitro fermentations to obtain more insight into the metabolism and production of succinic acid by bifidobacteria. Changes in end product formation in strains of Bifidobacterium could be related to the specific rate of sugar consumption. When the specific sugar consumption rate increased, relatively more lactic acid and less acetic acid, formic acid, and ethanol were produced, and vice versa. All Bifidobacterium strains tested produced small amounts of succinic acid; the concentrations were not more than a few millimolar. Succinic acid production was found to be associated with growth and stopped when the energy source was depleted. The production of succinic acid contributed to regeneration of a small part of the NAD+, in addition to the regeneration through the production of lactic acid and ethanol.

Abstract Ulcerative colitis (UC) pathogenesis includes the altered gut microbiota, environmental factors, and human immune and genetic predisposition. Recently, its association with reduced bifidobacteria quantity in the microbiota is reported.Xyloglucan, a plant based prebiotic oligosaccharide, causes increase in bifidobacteria quantity. In this article we share the results of our UC cases treated by intracolonic single dose administration of Bifidobacterium animalis subsp. Lactis and xyloglucan combination. Intracolonic single dose administration of 200 billion CFUs of Bifidobacterium animalis subsp. lactis and 4 gr of xyloglucan combination was administrated to ten severe UC patients, who were either unresponsive or had inadequate response to treatment. All patients continued treatment after the procedure. Treatment responses were evaluated by colonoscopic, laboratory and clinical examination after 6 weeks. Intracolonic single dose administration of Bifidobacterium animalis subsp. lactis and xyloglucan was found effective in the mucosal healing and resolution of colonic symptoms in ulcerative colitis patients. Intracolonic administration of Bifidobacterium animalis subsp. lactis and xyloglucan in UC is a new single strain and strain specific prebiotic combination method. It is easy to apply and has no observable side effect. Its effectiveness on mucosal healing could be attributed to the enhancement of non-stimulatory status and biodiversity in colonic mucosa. Nonetheless, it is still necessary to develop diagnostic strategies to determine the patients to whom this method would be the most applicable.

Abstract AIMS OF THE STUDY According to International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus (2019),Postbiotics are defined as a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host. Postbiotic Alginic acid, also called algin, is a naturally occurring, edible exopolysaccharide found in brown algae. Alginic acid and its Na/Ca salt form of Alginate show the capability in water-binding, water-retention water, and immense swelling and gelation, which could act as a protective barrier via promoting biofilm formation on the bacterial cell surfaces. Alginic acid is a potent inducer of Th1 pathway.We aimed to analyze the Postbiotic alginate formed by the human intestinal beneficial bacteria, bifidobacteria,by degrading sodium alginate. METHODS In these study, which were designed in Yildiz Technical University / Istanbul, Biohybrid films were produced by using both Bifidobacterium animalis subsp.lactis BB-12 probiotic strain and Bifidobacterium infantis in combination with sodium alginate (SA), which demonstrates biocompatibility and facilitated gelation properties in aeorobic atmospheric condition were considered as bifidobacterial surfactan source. RESULTS In biohybrid biofilm study(1), based on the spectroscopic and mechanical analysis, it was found that mechanical strength increased in films produced by adding Bifidobacterium infantis in SA while this increase was relatively lower as compared to those containing Bifidobacterium animalis subsp. lactis BB-12 as crosslinking ratio increases. Besides, bacteria contained in bio-hybrid films increased the percentage of amorphous zone of SA in SA/bacteria films, which reduced the crystallinity ratio. This indicated that crystalline chains contained in the structure of SA are degraded by probiotic bifidobacteria(Fig.1) CONCLUSIONS This is the first study that Biohybrid biosurfactan that contains Bifidobacterium infantis, Bifidobacterium animalis subsp. lactis BB-12 and SA structures coated medical/nonmedical devices and sets can be a pioneering approach to reduce carbon emissions, as well as to prevent secondary infections and increase device protection. Also, It paved the way for the postbiotic use of alginic acid/Alginate by probiotic Bifidobacteria.

Abstract Probiotic potential of two bifidobacterial strains isolated from feces of healthy adults and identified as Bifidobacterium animalis subsp. lactis was evaluated using in vitro testing. The analyzed strains were able to ferment a broad spectrum of carbohydrates, produced bioactive exopolysaccharides, demonstrated high survival rate in model GIT conditions, under heat and oxidative stresses, inhibited growth of a wide range of pathogenic and opportunistic bacteria, and proved to be safe for biotechnological application. Based on the complex phenotypic characteristics tested, Bifidobacterium animalis subsp. lactis may be regarded as prospective probiotic cultures.

Bifidobacterium spp. são microrganismos probióticos que podem ser incorporados em produtos alimentícios. Entretanto, para que seus efeitos benéficos à saúde humana ocorram, é necessário que o número de células viáveis na hora do consumo seja, no mínimo, 106UFC/g. As bifidobactérias são sensíveis à elevada acidez e, por isso, torna-se necessária a busca por métodos que possam proteger a integridade da célula, sendo um deles a microencapsulação. Em uma primeira etapa do trabalho, Bifidobacterium lactis foi encapsulado em micropartículas de alginato e alginato modificado (alginatoquitosana, alginato-quitosana-sureteric e alginato-quitosana-acryl-eze) e sua sobrevivência e liberação das micropartículas em fluidos simulados do trato gastrintestinal foram mensuradas utilizando-se soluções tampão com pH 1,5, 5,6 e 7,5, na presença e na ausência de pepsina (3g/L), pancreatina (1g/L) e bile (10g/L). A liberação de células das micropartículas teve uma relação direta com o pH do tampão. A microencapsulação aumentou a taxa de sobrevivência de B. lactis, em comparação com células não encapsuladas, em soluções tampão com pH 1,5 sem a presença de enzimas. Em suco gástrico simulado com enzimas digestivas, por outro lado, foi observado que a pepsina proporcionou um efeito protetor sobre as células de B. lactis, e nesse caso, as taxas de sobrevivência do microrganismo estavam diretamente relacionadas com o grau de injúria das células. Em uma segunda etapa do trabalho, leites fermentados com Streptococcus salivarius ssp. thermophilus e Lactobacillus delbrueckii ssp. bulgaricus foram enriquecidos com culturas de Bifidobacterium lactis submetidas a quatro tratamentos diferentes: desidratação em temperatura ambiente, liofilização/congelamento, encapsulação em alginatoquitosana e encapsulação em alginato-quitosana-acryl-eze. A população sobrevivente de B. lactis foi determinada semanalmente no leite fermentado e também após tratamento simulando condições do trato gastrintestinal. Os resultados indicaram que na ausência de pepsina, as populações de B. lactis foram reduzidas drasticamente após o contato com tampão pH 1,5, não sendo possível a detecção de células viáveis livres ou encapsuladas após 120 minutos de teste. A presença de pepsina influenciou positivamente a recuperação de células viáveis de B. lactis em todas as condições testadas, mas as culturas na forma desidratada apresentaram melhores resultados que as culturas microencapsuladas ou liofilizadas. No caso do leite fermentado contendo as células desidratadas, a população de B. lactis, após o tratamento em suco gástrico com enzimas, foi superior à detectada no produto antes desse tratamento. Conclui-se que a microencapsulação não foi eficiente para proteger B. lactis em leite fermentado contra injúrias causadas pelo trato gastrintestinal simulado.
Bifidobacterium spp. are microorganisms that can be added to foods. However, the benefits for the human health occur when the numbers of viable cells in the moment of the consumption is at least 106CFU/g. Bifidobacteria are acid sensitive, and methods to protect cell integrity, such as microencapsulation, are needed. In the first part of the present study, Bifidobacterium lactis was encapsulated in microparticles of alginate and modified alginate (alginate-chitosan, alginate-chitosan-sureteric and alginate-chitosan-acryl-eze) and the survival and release from microparticles in simulated gastrointestinal conditions were measured, using buffers (pH 1.5, 5.6 and 7.5), in the absence and presence of pepsin (3g/L), pancreatin (1g/L) and bile. The release from microparticles presented a direct relationship with pH. When the pH was 1.5 and no enzyme was present, encapsulation improved the survival of B. lactis, when compared to free cells. However, pepsin had a protective effect on B. lactis, and the survival rate was directly related to the cells injury degree. In the second part of the study, fermented milk samples containing Streptococcus salivarius ssp. thermophilus and Lactobacillus delbrueckii ssp. Bulgaricus were supplemented with B. lactis submitted to four different treatments: dehydration at room temperature, freeze drying, encapsulation in alginate-chitosan and encapsulation in alginate-chitosaacryl-eze. The number of viable B. lactis cells in the fermented milk was determined weekly and also after treatment with simulated gastrointestinal conditions. Results indicated that in the absence of pepsin, the number of viable cells decreased significantly after contact with buffers (pH 1.5), and no viable cell was detected after 120 minutes. Pepsin improved the recovery of viable cells in the assayed gastric conditions, being the dehydrated cultures more resistant than other cultures. In fermented milk containing the dehydrated cells, the number of viable cells increased after treatment with simulated gastrointestinal fluids. Microencapsulation was not an effective procedure to protect B. lactis in fermented milk against injury caused by the simulated gastrointestinal tract.

Probiotics are living organisms which exert a beneficial health effect when consumed in sufficient numbers. Consumer interest in probiotics has increased dramatically in recent years prompting an increase in production and development of functional foods. One major problem is the decreased viability of probiotic bacteria during functional food production and storage and subsequent digestion due to environmental stresses. The most common probiotic strains belong to the genus Lactobacillus or Bifidobacterium. Due to the anaerobic nature of these bacteria, they lack the required defense mechanisms for oxidative stress inherent in aerobic microorganisms. This study examined the oxidative stress responses of six strains of Bifidobacterium, which are commonly used as probiotics in functional foods.The first phase of the study investigated the innate and inducible hydrogen peroxide (H2O2) stress response of Bifidobacterium longum strains NCC2705 and D2957, Bifidobacterium longum ssp. infantis ATCC 15697, and Bifidobacterium animalis ssp. lactis strains BL-04, DSM10140 and RH-1. Strains were screened for survival at increasing concentrations of H2O2 and lethal and sublethal concentrations were determined for each. In the second phase, B. animalis ssp. lactis strains BL-04 and DSM10140 and B. longum strains NCC2705 and D2957 were treated with a sublethal H2O2 concentration and RNA samples were collected for transcriptome analysis after 5 min and either 20 or 60 min. Statistical analysis was performed to identify genes that increased or decreased in expression during H2O2 treatment compared to control cells.Results showed that survival was species and strain dependent and that strains which naturally survived higher H2O2 concentrations had a larger number of differentially expressed genes early on during H2O2 exposure. Some of the protective genetic systems that were activated during H2O2 stress are mechanisms which perform basic cellular functions under normal conditions such as deoxuynucleotide synthesis. Under stress conditions, these systems can be used to detoxify oxidative free radicals. Also a number of genes involved in sugar transport and energy production for the cell showed increased expression, which reveals the increased energy needs of the cells during oxidative stress.During testing, it was found that two B. animalis ssp. lactis strains, BL-04 and DSM10140, had differing levels of survival and gene expression during H2O2 exposure despite having almost identical genome sequences. It was determined that one possible cause of the differences was a genetic deletion in a gene that allows the cell to incorporate extracellular fatty acids into the cell membrane instead of synthesizing them.Results from this project have increased the understanding of oxidative stress responses in bifidobacteria and highlighted possible methods to increase bacterial survival during food manufacture, storage, and human digestion.

Existe um número muito limitado de estudos referentes à produção de componentes antimicrobianos ou bacteriocinas produzidas por espécies de bifidobactérias. Nesse âmbito, o objetivo deste trabalho foi avaliar a produção de bifidobacteriocina em leite desnatado (LD). Para tanto, o estudo foi dividido em três etapas. A primeira etapa constituiu na preparação dos meios de cultura Man, Rogosa e Sharpe (MRS), Bifidus Selective Medium (BSM) e LD suplementado com 1% (p/v) de Tween 80 (T80), Inulina (I) ou Extrato de levedura (YE). Nesta etapa, os processos fermentativos foram conduzidos em shaker, nas condições: 50 rpm/37ºC/48h. Foram realizadas análises de pH, concentração de açúcares e ácidos, crescimento celular e determinação da atividade da bifidobacteriocina pelo método de difusão em ágar contra L. monocytogenes. Na segunda etapa, e baseado nos resultados obtidos, foi desenhado um delineamento composto central (CCD) construído a partir dos seguintes parâmetros: temperatura (34, 37, 40 °C) e concentração de YE (0,5; 1,0; 1,5 g/L). Na terceira etapa do trabalho, foram realizados os cultivos em biorreator de 2 L, contendo 10% de leite desnatado, nas seguintes condições: 200 rpm, 36°C, 2,0 g/L de YE, 48h de incubação em anaerobiose. Obteve-se em LD suplementado com YE (1%), combinado ao método de difusão em placa modificado (prévia refrigeração das placas por 12h), contra L. monocytogenes (2130 AU/mL), com uma fase exponencial de 24h, µm de 0,604/h. A otimização feita através do CCD permitiu atingir níveis de atividade de 3.000 AU/mL a 3.100 AU/mL (ensaios 7, 11 e 14, blocos 3 e 1) contra L. monocytogenes, em condições ótimas de crescimento de YE: 2,0 g/L1 e T°C: 36°C. A análise de regressão mostrou ser estatisticamente significativa a relação entre as variáveis: \"concentração de \"YE e temperatura\". Os resultados indicaram que o leite desnatado é um meio adequado para produção de bifidobacteriocina.
There are few publications that have been reported about bacteriocin production by Bifidobacterium species. Therefore, the aim of this work was measure bacteriocin production in skim milk by B. lactis. Consequently, this work was divided in three stages. First, MRS, BSM and LD medium were tested with additives (Tween 80 (T80), Inuline (I) or Yeast extract (YE)) for bacteriocin production and cellular growth. Fermentation processes were conducted in shaker under specific conditions: 50 rpm/37ºC/48h. pH; sugars; acids; biomass, and bacteriocin activity against L. monocytogenes, L. plantarum, E. coli, L. sakei e S. aureus strains were analyzed . In the second stage, based on the obtained results, a central composite design (CCD) was created using the parameters: temperature (34, 37, 40 ºC), and concentration of YE (0.5, 1.0, 1.5 g/L). After, the activity was measured by two methods of plates pre-diffusion (cooling and addition of Tween 20). Third step consisted of 2 L bioreactor cultivations containing 10% skim milk diluted in 1.5 L of water (6.5 pH), under 200 rpm, 36 ºC, 2.0 g/L of YE, 48h, under anaerobic condition. Finally, the cultures supplemented with LD and YE (1%) with a modified plate diffusion method (cooling plates for 12 h) showed bacteriocin activity against L. monocytogenes (2130 AU/mL) with an exponential phase of 24 h, µm of 0.604/h. The optimization performed using CCD resulted in a higher level of activity 3000 AU/mL to 3100 AU/mL mL (Run 7, 11 and 14, blocks 3 and 1) against L. monocytogenes, also with ideal growth conditions of YE: 2,0 g/L1 and T °C: 36 °C. The pH value varied between 6.4 and 4.0. Concentration of produced acid lactic varied from 3.03 to 4.72 g/L and biomass concentration from 3.4 to 11.1 Lg UFC/mL. Regression analysis was significant to the variables: YE concentration and temperature. Results indicated that skim milk is a proper medium for \"Bifidobacteriocin\" production.

Bibliography: leaves 167-195.
The primary aim of the project was, therefore, to analyse carbohydrate metabolism for the identification of and/or the development of prebiotic substrates, and to provide a molecular characterisation for their utilisation. Several carbohydrates were tested for their ability to support the growth of bifidobacteria as a sole carbohydrate source. The four bifidobacterial strains, B. breve, B. bifidum, B. longum and B. lactis were able to utilise a wide variety of substrates.

Objetivou-se a produção de bacteriocina de Bifidobacterium animalis subsp. lactis, comparando-se os meios de cultivo sintéticos BSM (Bifidus Selective Medium) e MRS (Man Rogosa and Sharpe) com o meio de cultivo natural (soro de leite). Inicialmente, foram determinadas curvas de crescimento e de pós-acidificação, consumo de glicose, lactose e produção de bacteriocina de B.lactis através de processos fermentativos utilizando os meios de cultivo BSM, MRS e soro de leite (SL). Os microrganismos indicadores utilizados no teste de sensibilidade à bacteriocina produzida por B. lactis foram Lactobacillus sakei, Escherichia coli e Listeria monocytogenes. Considerando a cepa B. lactis uma espécie de bactéria aerotolerante, foi realizado, em meio de cultura BSM, estudo prévio avaliando o seu crescimento, com a variação da agitação (25, 50 e 100 rpm) e com tempo de cultivo de 30 h, a 37°C de temperatura. Os melhores resultados de crescimento celular (9,4 log UFC/mL) foram obtidos na agitação de 50 rpm. Determinada a melhor condição de agitação (50 rpm) e temperatura (37°C), foi realizado, em soro de leite, estudo de crescimento, acidificação e consumo de lactose, variando a concentração de sólidos totais dissolvidos (5, 10, 15, 20 e 25% p/v), para se estabelecer a concentração de soro de leite ideal para os estudos de suplementação. A maior quantidade de biomassa produzida, aliada à menor pós-acidificação, foi encontrada em soro de leite a 10% (p/v) de sólidos totais, no qual o microrganismo apresentou, ao final do cultivo (30 horas), contagem de 9,13 log UFC/mL e valor de pH 4,29, respectivamente. Também se verificou a influência dos meios de cultivo no crescimento e na produção de bacteriocina de B. lactis em agitador rotativo (shaker), que consistiu na análise comparativa do efeito da suplementação de 1% dos seguintes ingredientes: extrato de levedura (EL), inulina (I), L-cisteína (CI) e Tween 80 (T80). As melhores condições de cultivo encontradas para a maior produção de biomassa e bacteriocina foram obtidas no soro de leite, à concentração de 10% (p/v) suplementado com 1% de extrato de levedura (9,9 log UFC/mL e 200 UA/mL). Na etapa final do trabalho, estas condições foram testadas em fermentador de bancada, quando foi observado que o crescimento de Bifidobacterium lactis foi 10% maior em relação ao agitador rotativo. Quanto à atividade da bacteriocina produzida em fermentador de bancada, não houve diferença em relação ao agitador rotativo (200 UA/mL). Esta diferença no crescimento pode ser devido as melhores condições de anaerobiose oferecidas em fermentador de bancada, no qual houve a injeção de nitrogênio no meio de cultivo, sendo que, no agitador rotativo, a condição de anaerobiose foi gerada por um agente externo ao meio (uso de jarras de anaerobiose). Através do presente trabalho, pode-se concluir que a produção de bacteriocina por B. lactis é viável e apresenta resultados promissores quando utilizada a combinação soro de leite adicionado de extrato de levedura, o qual apresentou atividade antimicrobiana contra a cepa Listeria monocytogenes. A otimização do processo em fermentador de bancada demonstrou-se interessante quanto à produção de bacteriocina em nível industrial.
The objective was the production of bacteriocins by Bifidobacterium animalis subsp. lactis, comparing the synthetic culture medium BSM (Bifidus Selective Medium) and MRS (Man Rogosa and Sharpe) with the natural culture medium (whey). Initially, growth and post-acidification curves were determined, consumption of glucose, lactose and B. lactis bacteriocin production by fermentation processes using culture media BSM, MRS and milk whey (SL).The indicator organisms used in the test sensitivity to bacteriocin produced by B. lactis were Lactobacillus sakei, Escherichia coli and Listeria monocytogenes. Given the strain B. lactis one aerotolerant species of bacteria, it was conducted in culture medium BSM, a preliminary study assessing the growth, by varying the agitation (25, 50, and 100 rpm) with cultivation time of 30h at 37°C temperature. The best results of cell growth (9.4 log CFU / mL) were obtained at 50 rpm agitation. After the best condition of agitation (50 rpm) and temperature (37°C) determination, it was performed on whey, a study of growth, acidification and consumption of lactose, varying the concentration of total dissolved solids (5, 10, 15, 20 and 25% w/v), to settle the best concentration of whey for studies of supplementation. The highest amount of biomass produced, combined with the lowest post acidification was found in whey at 10% (w/v) of total solids, wherein the microorganism presented at the end of culture (30 hours) a counting of 9.13 log CFU/mL and pH 4.29, respectively. It was also verified the influence from the culture media on B. lactis growth and production of bacteriocin on a rotary shaker (shaker), which was the comparative analysis from the effect of supplementation by 1% of the following ingredients: yeast extract (EL), inulin (I), L-cysteine (IC) and Tween 80 (T80). The best growing conditions found for higher biomass and bacteriocin production were obtained from the whey concentration of 10% (w/v) supplemented with 1% yeast extract (9.9 log CFU/ml to 200 AU/mL). In the final stage of the work, these conditions were tested in bench fermentor, where it was observed that the growth of Bifidobacterium lactis was 10% higher than in the rotary shaker. Regarding the activity of bacteriocin produced in fermenter bench, there was no difference in the rotary shaker (200 AU / mL). This difference in growth may be due to the better anaerobic conditions offered in bench fermentor, which was the injection of nitrogen into the medium, and in a rotary shaker, the anaerobic condition was generated by an external agent to the medium (use of anaerobic jars). Through this study, it can be concluded that bacteriocin production by B. lactis is achievable and shows promising results when used the combination whey added yeast extract, which showed antimicrobial activity against the strain Listeria monocytogenes. The optimization process bench fermentor has been shown interesting as bacteriocin production at industrial level.

Made available in DSpace on 2015-04-17T14:49:38Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 738842 bytes, checksum: f859e9c142cb3bfbdc96142d10b83ea5 (MD5) Previous issue date: 2014-06-06
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
The development of functional goat dairy products is a viable alternative to add value to goat milk and to popularize new functional foods, considering the growing demand for foods with high nutritional quality, tasteful and promoters of well-being and health. This study aimed to produce chocolate goat dairy beverages with the probiotic Bifidobacterium lactis and evaluate the effects of goat cheese whey and prebiotics (inulin and oligofructose) on the physicochemical parameters and sensory features of the beverages during 28 days of refrigerated storage. Seven formulations of dairy beverages were analyzed for protein, fat, ash and lactose immediately after production, and submitted to physicochemical analysis (titratable acidity, total solids, pH, syneresis, apparent viscosity) and microbiological analysis, including B. lactis viability, after 1, 7, 14, 21 and 28 days. Sensory acceptability was determined after 14 days. All formulations had decreased pH and concomitant increase in the acidity during refrigerated storage. Beverages made with the lowest amounts of whey (F1 and F3) had greater decrease in pH from 14 days of storage. The apparent viscosity increased up to 21 days for all formulations, and up to 28 days for F4 (6 g 100 g - 1 prebiotics and 45 mL 100 mL -1 whey), possibly related to the higher amounts of whey and inulin. B. lactis showed counts between 6 and 8 log CFU mL-1. F4 presented the highest average in sensory attributes flavor and aroma. Apparently, larger amounts of prebiotics and whey in the beverage enhance the flavor perception, which may be a consequence of the intensification of cocoa flavor and / or lower acidity perception. Thus, F4 was the formulation that best represented the desirability profile chosen for the probiotic chocolate goat dairy beverage as best viscosity and improved sensory features.
O desenvolvimento de derivados lácteos funcionais de cabra é uma alternativa viável para agregação de valor ao leite de cabra e popularização de novos alimentos funcionais, considerando a crescente demanda por alimentos com qualidade nutricional, sabor agradável e promotores de bem-estar e saúde. O objetivo deste estudo foi elaborar bebidas lácteas achocolatadas de cabra (F1 a F7) contendo Bifidobacterium lactis e avaliar os efeitos do soro de queijo de cabra e do prebiótico Synergy 1® (inulina e oligofrutose) sobre as propriedades físico-químicas e sensoriais durante 28 dias de armazenamento refrigerado. As bebidas lácteas foram avaliadas imediatamente após a fabricação quanto à proteína, gordura, cinzas e lactose, submetidas às análises físico-químicas (acidez titulável, sólidos totais, pH, sinérese, viscosidade aparente) e microbiológicas, incluindo a viabilidade da B. lactis, durante o armazenamento após 1, 7, 14, 21 e 28 dias. Após 14 dias de armazenamento foi determinada a aceitabilidade sensorial. Todas as formulações tiveram uma diminuição do pH concomitante a um aumento na acidez ao longo do armazenamento refrigerado. As bebidas formuladas com menor quantidade de soro (F1 e F3) tiveram uma queda maior no pH a partir de 14 dias de armazenamento. As formulações F3 e F4 (contendo 6 g 100 g-1 de prebiótico) apresentaram teor de sólidos totais significativamente mais elevados. A viscosidade aparente aumentou até 21 dias em todas as formulações, e para F4 (maiores proporções de soro e de prebióticos - 45 mL 100 mL-1 e 6 g 100 mL-1 - respectivamente) este aumento se estendeu até os 28 dias, possivelmente relacionado à influência do soro e da inulina. Durante todo o período estudado B. lactis apresentou contagens entre 6 e 8 log UFC mL-1, sendo a maior viabilidade observada para a formulação F1 (8,13±0,03 UFC mL-1). A maior mediana nos atributos sabor e aroma foi observada para F4. Aparentemente uma maior quantidade de prebiótico na bebida melhorou a percepção do sabor, o que pode ser uma consequência da intensificação do sabor de cacau e ou da menor percepção da acidez. Já o aumento do soro melhorou a percepção do aroma na bebida láctea. Assim, F4 foi a formulação que melhor representou o perfil de desejabilidade escolhido para a bebida láctea probiótica achocolatada de cabra, como melhor viscosidade e características sensoriais.

Thesis (MTech (Food Technology))--Cape Technikon, 2004
Probiotic foods are intended to supply selected viable microorganisms, for example Lactobacillus acidophilus and Bifidobacterium, to consumers. These organisms, when consumed at the daily intake of 108 , provide benefits beyond basic nutrition. Probiotic (AB) foods generally include fermented dairy products such as yoghurts and cheeses, targeted at the upmarket consumer. However, due to technical problems associated with the foods and the organism, viable Bifidobacterium rarely occur in AB foods. The principle aims of this study were to develop a suitable delivery system for Bifidobacterium to the consumer, and to supply these living organisms in the affordable traditional fermented African beverages, amasi and mahewu. This would provide the benefits of probiotics to the rural African consumer, where malnutrition and gastrointestinal diseases occur. The organism selected for this study was Bifidobacterium lactis DSM 10140, commonly associated with AB starter cultures for yoghurts. The delivery system selected was microencapsulation of B. lactis using a mixture of the generally recognised as safe (GRAS) edible gums, gellan and xanthan. Supply vehicles for the microcapsules to the consumer were amasi and mahewu. Prior to microencapsulation, rheological studies were undertaken to determine whether the gellan-xanthan gum mix would provide a suitable support matrix for microencapsulated B. lactis. This was done using a Paar Physica MGR 300 rotational rheometer with a cone plate 50-2 measuring system. Results indicated that the hydrated gellan-xanthan gum mix behaved as a non-Newtonian material, and the flow curve fitted well to the Herschel-Bulkley model. This demonstrated that the gel was a relatively viscous material with solid properties. The average yield stress of the gel was 1.515 Pa, indicating that the gel was stable, and at lower stresses would behave as a solid. The gel mix would be disrupted by shear stresses associated with mastication and peristalsis. The minimum viscosity of the gel was constant at temperatures between 46°C - 61°C. It was concluded from these data that the gel was suitable for microencapsulation and that microcapsules should only be included in soft foods, which do not require chewing. Temperatures associated with microencapsulation, at minimum gel viscosities, were not lethal to B. lactis. Bifidobacterium lactis cells were incubated under anaerobic conditions (4% H2, 10% CO2, and 86% N2) at 37°C overnight in 250 ml Tryptone-Yeast-Glucose (TYG) broth, and grown to an 00600 0.9 - 1.1. Cells were harvested and washed for microencapsulation using centrifugation. Microencapsulation of the organism was done using a mono-axial extrusion technique together with a superposed airflow, by manually extruding the aqueous gum I cell mix through a 27.5 G bevelled needle, fitted on to a 10 ml syringe. The resultant microdroplets were hardened by free fall into 0.1 M CaCI2 solution. Microcapsules were separated from the CaCI2 solution by filtration through Whatman No.1 filter paper. All procedures were carried out in a laminar flow hood. Results indicated that the method of microencapsulation used in this study was successful. Using a concentrated inoculum of B. lactis, high numbers (lOglO 11-12 etu.g-1 ) of bacteria were incorporated into the microcapsules. Therefore the daily intake would be provided by 0.1 g microcapsules. The diameter and size distribution of microcapsules were determined by laser diffractometry. This showed a maximum microcapsule diameter of 2.22 mm with 50% (w/v) of the microcapsules having a diameter of < 0.637 mm. Although this represents a considerable size variation, this would not adversely affect mouthfeel of the beverages, as only 0.1 g microcapsules would be required to obtain at least 108 B. lactis in any volume of amasi or mahewu. To enumerate immobilised viable B. lactis, two techniques were compared. These involved the use of either a pestle and mortar, or high power ultrasound (HPUS) (20 kHz, 750 W). Results showed that HPUS was superior to the pestle and mortar technique. A short exposure (15 s) to HPUS disrupted the matrix releasing all entrapped etus, whereas when using the pestle and mortar xiii technique, cells remained partially entrapped in the gel. Therefore the pestle and mortar technique yielded lower cfu values than expected. The survival of microencapsulated B. lactis, in 1 M sodium phosphate buffer, was studied as a possible means of supply of microcapsules to industry for incorporation into foods. Microcapsules were stored in the buffer for 21 days at either 4°C or 22°C. Results showed that cell viability was not significantly reduced (p>0.05) at either temperature after 21 days. Hence this form of storage could be used to deliver viable immobilised B. lactis to the food industry. In order to assess the survival of immobilised B. lactis in the GIT, the microcapsules were incubated at 37°C over a period of 240 min in simulated gastric juice (SGJ) (pH 1.5). Viable counts were performed by sampling at regular intervals. A similar study was done in simulated bile and pancreatic juices (BPJ) (pH 6.5). In SGJ, it was demonstrated that there was a significant reduction (3 log cycles) (p<0.05) of free cells after 240 min. However, this trend was not noted for microencapsulated B. lactis. Therefore, the gellanxanthan gel matrix protected B. lactis from the lethal effect of SGJ. In BPJ, no significant difference (p>0.05) was noted for surviving fractions of both immobilised and free B. lactis. Commercial pasteurised amasi (pH 4.4) and mahewu (pH 3.5) were selected as the supply vehicles for the microencapsulated B. lactis. Known numbers of viable microencapsulated and free B. lactis cells were added to both beverages. For most samples, incubation was at either 4°C or 22°C for 21 days in the presence of atmospheric oxygen. In addition, free cells were incubated anaerobically at 22°C. As oxygen is limiting in the microcapsules, these were not incubated under anaerobic conditions. The survival I shelf-life studies of commercial amasi indicated no significant difference (p>0.05) in survival rate between immobilised and free B. lactis cells. The reduction noted for viable counts of immobilised or free B. lactis cells was approximately 1.5 log cycles. Even so, after 21 days viable immobilised B. lactis (1010 0.1 g'l microcapsules) remained in excess of the daily intake 108 , whereas in the free B. lactis cells, the viable count declined to 106 mr1 . Statistical analyses showed that temperature or oxygen presence had little effect on the survival of both immobilised or free B. lactis cells (p>O.05). In mahewu, decline in viability of cells was observed for most samples. However microencapsulation enhanced cell survival at both 4°C and 22°C when compared to free cells. The decrease in viable B. lactis free cells occurred more rapidly (3 log cycles) in mahewu, than in amasi, at both 4°C and 22°C. Throughout the shelf-life studies it was apparent that viable B. lactis cell numbers did not increase. This was advantageous as metabolites associated with B. lactis growth would have adversely altered the taste of both amasi and mahewu. Sensory evaluation of the traditional fermented African beverages, enriched with either viable immobilised or free B. lactis, was done in order to determine consumer response to the product. An analytically trained 12-member taste panel analysed the beverages for colour, texture, and taste. The triangle taste test procedure was used. No differences were detected with regard to texture, and colour of the fermented beverages containing immobilised B. lactis. However, in the fermented beverages containing free cells, a change in viscosity was noted. There was a significant difference (p